ArticleCurrent medical imaging2025
A Novel Fragmentation-based Approach for Accurate Segmentation of Small-Sized Brain Tumors in MRI Images.
Article in Current medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsIn the dynamic landscape of healthcare, integrating Artificial Intelligence paradigms has become essential for sophisticated brain image analysis, especially in tumor detection. This research addresses the need for heightened learning precision in handling sensitive medical images by introducing the Fragmented Segment Detection Technique.
backgroundThe ever-evolving healthcare landscape demands advanced methods for brain image analysis, particularly in detecting tumors. This study responds to this need by introducing the Feature Segmentation and Detection Technique (FSDT), a novel approach designed to identify brain tumors precisely using MRI images. The focus is on enhancing detection accuracy, even for diminutive tumors. The primary objective of this study is to introduce and evaluate the efficacy of FSDT in identifying and sizing brain tumors through advanced medical image analysis. The proposed technique utilizes cross-section segmentation and pixel distribution analysis to improve detection accuracy, particularly in size-based tumor detection scenarios.
methodsThe proposed technique commences by fragmenting the input through cross-section segmentation, enabling meticulous separation of pixel distribution in various sections. A Convolutional Neural Network then independently operates sequentially on the minimum and maximum representations. The segmented cross-section feature, exhibiting maximum accuracy, is employed in the neural network training process. Finetuning of the neural network optimizes feature distribution and pixel arrangements, specifically in consecutive size-based tumor detection scenarios.
resultsThe FSDT employs cross-sectional segmentation and pixel distribution analysis to enhance detection accuracy by leveraging a diverse dataset encompassing central nervous system CNS tumors. Comparative evaluations against existing methods, including ERV-Net, MRCNN, and ENet- B0, reveal FSDT's superiority in accuracy, training rate, analysis ratio, precision, recall, F1-score, and computational efficiency. The proposed technique demonstrates a remarkable 10.45% increase in accuracy, 14.12% in training rate, and a 10.78% reduction in analysis time.
conclusionThe proposed FSDT emerges as a promising solution for advancing the accurate identification and sizing of brain tumors through cutting-edge medical image analysis. The demonstrated improvements in accuracy, training rate, and analysis time showcase its potential for effective realworld healthcare applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.